Home » Prices » NASDAQ:CTMX

CytomX Therapeutics, Inc. stock price

Today's NASDAQ:CTMX chart, history & news

Price:
7.42 USD
Change:
+0.07 (0.95%)
Key Stats
Price open 7.37
Previous close 7.35
Market cap 342.99M
Volume 187.99K
Day high 7.47
Day low 7.3
Year high 14.64
Year low 3.61
Year to date change -12.72%
P/E Ratio N.A
Company Profile
Fundamentals
Insider Information
News

About CytomX Therapeutics, Inc.

CytomX Therapeutics, Inc. engages in the development of antibody therapeutics for the treatment of cancer based on its Probody therapeutic technology platform. Its pipeline includes immunotherapies, probody drug conjugates, T cell engaging bispecifics, and other multiple programs. The company was founded by Frederick W. Gluck and Nancy E. Stagliano in September 2010 and is headquartered in South San Francisco, CA.

Company information

Company name
CytomX Therapeutics Inc
Exchange
Sector
Health Technology
Industry
Biotechnology
Employees
158
CEO
Sean A. McCarthy
Address
151 Oyster Point Boulevard, South San Francisco, CA, 94080-1913
Country
United States
Contact information
1.605.515.3185
Website
http://www.cytomx.com

Related companies

Invezz uses cookies to provide you with a great user experience. By using Invezz, you accept our privacy policy.